{"result": "(\"entity\"<|>PEDIATRÍA<|>EVENT<|>Pediatrics is a branch of medicine that deals with the medical care of infants, children, and adolescents, focusing on their nutritional needs and health issues.)\n##\n(\"entity\"<|>ENFERMEDADES CRÓNICAS<|>EVENT<|>Chronic diseases are long-term health conditions that may require ongoing medical attention and can affect nutritional needs in pediatric patients.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL CÍCLICA<|>EVENT<|>Cyclical enteral nutrition combines enteral feeding during specific hours with intermittent oral feeding, often used in pediatric care.)\n##\n(\"entity\"<|>FÓRMULAS POLIMÉRICAS<|>ORGANIZATION<|>Polymeric formulas are enteral nutrition products that contain intact proteins and are typically used for patients with normal digestive function.)\n##\n(\"entity\"<|>FÓRMULAS OLIGOMÉRICAS<|>ORGANIZATION<|>Oligomeric formulas are specialized enteral nutrition products with modified proteins, used for patients with significant digestive issues.)\n##\n(\"entity\"<|>TRIGLICÉRIDOS DE CADENA MEDIA<|>ORGANIZATION<|>Medium-chain triglycerides (MCT) are fats that are easily digestible and often added to enteral formulas for patients with specific dietary needs.)\n##\n(\"entity\"<|>NUTRIENTES<|>ORGANIZATION<|>Nutrients are substances that provide nourishment essential for the maintenance of life and for growth, often discussed in the context of enteral nutrition.)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>PEDIATRÍA<|>Pediatric nutrition is a critical aspect of pediatrics, focusing on the dietary needs of children<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL CÍCLICA<|>NUTRICIÓN ENTERAL<|>Cyclical enteral nutrition is a method of providing enteral nutrition to patients<|>6)\n##\n(\"relationship\"<|>FÓRMULAS POLIMÉRICAS<|>NUTRICIÓN ENTERAL<|>Polymeric formulas are a type of enteral nutrition product used for patients with normal digestive function<|>6)\n##\n(\"relationship\"<|>FÓRMULAS OLIGOMÉRICAS<|>NUTRICIÓN ENTERAL<|>Oligomeric formulas are a type of enteral nutrition product used for patients with significant digestive issues<|>6)\n##\n(\"relationship\"<|>TRIGLICÉRIDOS DE CADENA MEDIA<|>FÓRMULAS OLIGOMÉRICAS<|>Medium-chain triglycerides are often added to oligomeric formulas to enhance digestibility<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>NUTRIENTES<|>Enteral nutrition provides essential nutrients to patients who cannot consume food orally<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: | 15 cc: 20, 22 F | 10, 14, 16, 18, 20 F | 15 F gastropexia 15 F sustitución | 7 cc: 12, 14, 16 F 15 cc: 18 a 30 F Para bolus: 7 cc: 12, 14, 16 F 20 cc: 18 a 24 F |\n| Sonda sin balón | 16, 20 F | - | - | - | - |\n| Botón | 18, 24 F (1,2, 1,7, 2,4, 3,4 cm) 24 F (4,4 cm) 28 F (1,5, 2,7, 4,3 cm) | - | - | - | - |\n| Botón con balón | 10, 20 cc: 16 F (1,2, 1,7, 2,4 cm) 18, 20 F (1,7, 2,4, 3,4, 4,4 cm) 20 cc: 16 F (1,7, 2,4 cm) 20, 24 F (1,7, 2,4, 3,4, 4,4 cm) | - | - | - | <10 cc: 12 a 20 F (0,8, 1, 1,2, 1,5, 1,7, 2,0, 2,3, 2,5, 2,7, 3, 3,5, 4 cm) 14 a 20, 24 F (4,5 cm) 24 F (5 cm) |\n\nPEG: Gastrostomía endoscópica percutánea. F: French (1 F = 0,33 mm) E: Endoscopia.\nFuente: datos proporcionados por las casas comerciales según su vademécum de productos 2016.\n\npediatría, por disminuir la incidencia de trastornos de la alimentación asociados a la nutrición enteral prolongada, es la nutrición enteral cíclica, en la que se combinan la administración de fórmula por vía enteral durante unas horas (generalmente por la noche) y la alimentación oral intermitente (habitualmente durante el día).\n\n## 6. Selección del tipo de fórmula\n\nHay varios factores que determinan la elección de la fórmula a utilizar en cada paciente¹⁰, ¹¹, siendo los más importantes la edad, el grado de funcionalidad del intestino y la enfermedad de base del paciente¹, ⁴, ⁵.\n\nSi la función digestiva permanece íntegra o solo existe intolerancia a la lactosa, las dietas poliméricas convencionales son las de primera elección a partir del año de edad. Cuando el paciente presenta alteraciones digestivas importantes, dependiendo de la función afectada, puede ser necesario el uso de fórmulas con modificaciones en las proteínas (oligoméricas o elementales) o grasas (con adición de triglicéridos de cadena media, MCT).\n\nLa elección de la fórmula también está condicionada por la enfermedad de base que padece el niño, de modo que pueden ser recomendables ciertos preparados con exclusión de algunos nutrientes u otros específicamente diseñados para adecuarse a las alteraciones metabólicas y a los requerimientos nutricionales de una enfermedad determinada.\n\n### 6.1. Suplementos orales\n\nExisten preparados comerciales tipo suplemento (fórmulas incompletas de alta palatabilidad) que se caracterizan por su alto contenido calórico. Contienen proteínas intactas, triglicéridos de cadena larga (LCT) y carbohidratos sencillos y su osmolalidad es elevada (450 a 600 mOsm/kg). En general, solo están indicadas en pacientes con función gastrointestinal normal. Se presentan en polvo para diluir con leche, o en forma líquida, sólida o semisólida. Las fórmulas poliméricas completas tanto pediátricas como de adultos, saborizadas, pueden utilizarse como suplementos orales¹².\n\nLa ingesta de grandes volúmenes de estos preparados puede no ser tolerada en los pacientes nutricionalmente comprometidos; por tanto, se recomienda el consumo frecuente de pequeñas alícuotas o su uso sustituyendo a la leche del desayuno y de postre de la cena.\n---\n## BLOQUE: NUTRICIÓN PEDIÁTRICA\n\n### 6.2. Fórmulas a partir de alimentos naturales\n\nLas fórmulas comerciales se fabrican con carne, huevos, leche, cereales, frutas y verduras y aceites vegetales. Contienen una cantidad moderada de residuo y una osmolalidad de entre 300 y 450 mOsm/kg. Son útiles para los pacientes con enfermedades crónicas que tienen una capacidad digestiva adecuada y necesitan soporte nutricional enteral a largo plazo. Sin embargo, pueden no ser toleradas por los niños con una función intestinal comprometida. Suelen ser caras y\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>GASTROSTOMÍA ENDOSCÓPICA PERCUTÁNEA<|>EVENT<|>Gastrostomía endoscópica percutánea is a medical procedure used for enteral nutrition in patients with feeding disorders.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Nutritional support provided through enteral feeding, often used in pediatric patients to address feeding disorders.)\n##\n(\"entity\"<|>NUTRICIÓN PEDIÁTRICA<|>EVENT<|>Pediatric nutrition focuses on the dietary needs and nutritional support for children, especially those with feeding difficulties.)\n##\n(\"entity\"<|>FÓRMULAS COMERCIALES<|>ORGANIZATION<|>Commercial formulas are nutritional products designed for enteral feeding, made from various natural ingredients.)\n##\n(\"entity\"<|>ALIMENTOS NATURALES<|>ORGANIZATION<|>Natural foods used in the preparation of enteral formulas, including meat, eggs, milk, cereals, fruits, and vegetables.)\n##\n(\"relationship\"<|>GASTROSTOMÍA ENDOSCÓPICA PERCUTÁNEA<|>NUTRICIÓN ENTERAL<|>Gastrostomía endoscópica percutánea is a procedure that facilitates enteral nutrition for patients with feeding disorders<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>NUTRICIÓN PEDIÁTRICA<|>Enteral nutrition is a key component of pediatric nutrition, especially for children with feeding difficulties<|>7)\n##\n(\"relationship\"<|>FÓRMULAS COMERCIALES<|>NUTRICIÓN ENTERAL<|>Commercial formulas are used in enteral nutrition to provide necessary nutrients to patients<|>6)\n##\n(\"relationship\"<|>ALIMENTOS NATURALES<|>FÓRMULAS COMERCIALES<|>Natural foods are the basis for the preparation of commercial formulas used in enteral nutrition<|>5)\n<|COMPLETE|>"}]}